Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:e9056
doi: 10.1161/hc4801.103077
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SoRelle, R.

(Circulation. 2001;104:e9056.)
© 2001 American Heart Association, Inc.

Myocyte Implants Appear Feasible and Safe

Ruth SoRelle, MPH

Circulation Newswriter

Ten patients have received transplants of myocytes placed into the weakened areas of their hearts at the same time that they underwent coronary artery bypass graft surgery at the Hopital Bichat in Paris, France, according to Phillipe Menasche, MD, PhD, Professor of Thoracic and Cardiovascular Surgery at the Hopital Bichat, speaking at the 2001 Scientific Sessions of the American Heart Association in Anaheim, Calif.

"I have now operated on 10 patients with severe heart failure who had suffered myocardial infarctions," said Dr Menasche on November 13, 2001. "Overall, it is a safe procedure. There are no particular complications related to 56 punctures to put the cells in. Some patients suffered arrhythmias 2 weeks later. I think it’s honest to say that this is a potential adverse event associated with the procedure. But it is a transient event." Dr Menasche said he had implanted defibrillators in some patients, but the abnormal rhythm had not returned. He could not conclude as to the efficacy of the trial as yet.

"In terms of feasibility, we can be happy. Can you take a piece of muscle, grow it in 2 weeks and put it back? Yes, it can be routine," he said. Dr Menasche implanted the cells into the scar left by the heart attack at the time of bypass surgery. "The area where the cells were implanted was not revascularized," he said.

In a separate study, Patrick W. Serruys, MD, of the Thoraxcenter in Rotterdam, the Netherlands, said he had attempted an endovascular . . . [Full Text of this Article]